Saturday, June 20
11am - 6pm ET
UHMS will be hosting a live Webinar "Evidence Review for HBO2 Treatment of COVID-19" on June 20, 2020 from 11am - 6pm ET. This webinar will feature a comprehensive look at the issues surrounding the use of HBO2 for COVID-19. We will be reviewing abstracts submitted by researchers from around the world and will be synthesizing the information into a report that will be posted at a future date. We will feature topics on epidemiology of COVID-19, clinical course of COVID-19, safety concerns, pre-trial studies, case reports and more. See schedule below and register today.
Webinar platform: Go-To-Webinar
Schedule Posted: 5-27-2020
|Start time||End time||Lecture||Faculty|
|11:00||11:05||Introduction||Nick Bird, MD|
|11:05||11:20||Session 1: Pathophysiology of COVID-19
This session will give an overview of the SARS-CoV-2 virus, its transmission, and how it acts on the body.
|Kialing Perez, MD|
|11:20||11:25||Q & A|
|11:25||11:40||Session 2: Clinical course of COVID-19 and the possible role of HBO2Moderator: TBD
This session will describe the clinical course of COVID-19 from asymptomatic patients through ventilated patients, identifying any opportunities for intervention using HBO2. This session will also summarize the published clinical experience treating COVID-19 patients with HBO2.
|Sandra Wainwright, MD|
|11:40||11:45||Q & A|
Session 3: Safety concerns for the use of HBO2 in COVID-19 patientsModerator: TBD
|Scott Gorenstein, MD|
|12:00||12:05||Q & A|
|12:05||12:20||Session 4: Operational considerations for the use of HBO2 in COVID-19 patient
Moderator: Andrew Melnyczenko, CHT
This session will discuss operational considerations for facilities who intend to treat COVID-19 patients including:
|12:20||12:25||Q & A|
|12:25||1:40||Session 5: Translation of research into practiceModerator: TBD
This session will discuss the balance between compassionate use of HBO2 versus the need for IRB-approved, evidence-based research including strategies to translate limited evidence into clinical practice.
|Michael Bennett, MD|
|1:40||1:45||Q & A|
|2:45||3:00||Session 6a: abstract paper|
|3:00||3:15||Session 6b: abstract paper|
|3:15||3:30||Session 6c: abstract paper|
|3:30||3:45||Session 6d: abstract paper|
|3:45||4:00||Session 6e: abstract paper|
|4:00||4:15||Session 6f: abstract paper|
|4:15||5:00||Q & A|
|5:00||6:00||Session 7: Synthesis of the Data
Moderator: John Feldmeier, DO
This session will attempt to synthesize the data that has been presented into a cohesive document with three general goals:
|John Feldmeier DO|
- Give an overview of the SARS-CoV-2 virus, its transmission, and how it acts on the body.
- Describe the clinical course of COVID-19 from asymptomatic patients through ventilated patients, identifying any opportunities for intervention using HBO2. This session will also summarize the published clinical experience treating COVID-19 patients with HBO2.
- Discuss the potential hazards to COVID-19 patients that need to be addressed and studied including pulmonary oxygen toxicity and sick patients leaving ICU to go to HBO2 department.
- Discuss operational considerations for facilities who intend to treat COVID-19 patients including, infection control in the hyperbaric chamber and staff education.
- Discuss the balance between compassionate uses of HBO2 versus the need for IRB-approved, evidence-based research including strategies to translate limited evidence into clinical practice.
- Attempt to synthesize the data that has been presented into a cohesive document with three general goals:
- What questions have we answered?
- What questions still need to be answered?
- What elements of study design should be incorporated in future studies?
Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician CME: The Undersea and Hyperbaric Medical Society designates this live activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing CEU: This live activity is approved for 5 contact hours by the Florida Board of Registered Nursing Provider #50-10881. Licenses Types Approved: Advanced Registered Nurse Practitioner; Clinical Nurse Specialist; Licensed Practical Nurse; Registered Nurse; Certified Nursing Assistant; Respiratory Care Practitioner Critical Care; Respiratory Care Practitioner Non-Critical Care; Registered Respiratory Therapist; Certified Respiratory Therapist.
NBDHMT: This live activity is approved for 5 Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, 9 Medical Park, Suite 330, Columbia, South Carolina 29203.
Full Disclosure Statement
All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with commercial interests. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.
All individuals in control of educational content of this activity have no relevant financial relationships with commercial interest to disclose to include faculty, planners, moderators and reviewers. The full disclosure table can be provided upon request.